SynthesisFrontiers in medicine2026
Mapping the knowledge domain: a bibliometric analysis of global research on traditional Chinese medicine for non-alcoholic fatty liver disease (2000-2024).
Synthesis in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Non-alcoholic fatty liver disease (NAFLD) constitutes a significant global health burden with rising prevalence. While Traditional Chinese Medicine (TCM) exhibits growing potential in NAFLD intervention, no domain-specific bibliometric evaluation currently exists. Utilising the most recent data from authoritative bibliographic databases, this study conducts a comprehensive bibliometric analysis to delineate the knowledge structure, research fronts, and collaborative networks in this field. Methods: We searched for publications from 2000 to 2024 in the Web of Science Core Collection (WoSCC) database, encompassing a total of 855 papers. In addition, a supplementary search was conducted in the PubMed database to identify and analyze eligible clinical trials. Bibliometric analyses were performed utilising R software, VOSviewer, and CiteSpace. Results: Investigations into TCM about NAFLD have indicated a general upward trajectory. China leads in research output, succeeded by the United States and South Korea. Shanghai University of Traditional Chinese Medicine is the preeminent cooperative institution. Ji G ranks as the most productive author in this field, whereas Younossi ZM emerges as the most frequently co-cited scholar. Among journals, Journal of Ethnopharmacology publishes the largest number of articles, while Hepatology receives the highest citation frequency. Key research themes include gut microbiota, network pharmacology, inflammation, insulin resistance, and lipid metabolism. Research hotspots primarily concentrate on the mechanisms by which TCM compounds, like berberine and Lingguizhugan Decoction, have garnered considerable attention, and the utilisation of contemporary research methodologies, such as network pharmacology, has markedly intensified. Conclusion: This bibliometric analysis thoroughly outlines the current status and developmental tendencies of TCM research in NAFLD for the first time, offering significant references for future investigations in this domain.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.